Literature DB >> 21744993

The effects and mechanisms of blockage of STAT3 signaling pathway on IL-6 inducing EMT in human pancreatic cancer cells in vitro.

C Huang1, G Yang, T Jiang, G Zhu, H Li, Z Qiu.   

Abstract

Aberrant Signal transducers and activators of transcription-3 (STAT3) signaling pathway is a major cause of tumor invasion and metastasis; the underlying mechanisms, however, are not well understood. Epithelial-mesenchymal transition (EMT) is an early event that occurs during invasion of cancers of an epithelial origin. It remains elusive whether STAT3signaling pathway is involved in EMT. The objective of this study was to evaluate the effect of blockage of STAT3 signaling pathway on IL-6 inducing EMT in human pancreatic cancer cells. We used SW1990 cells and induced them to undergo EMT by exposing these cells to soluble factor interleukin-6 (IL-6). The expression of Snail, E-cadherin, and Twist was detected by reverse transcription-PCR, real-time PCR, and Western blotting. Cell morphology was observed under invert phase-contrast microscope.The invasion ability was determined by cell invasion assay in vitro. Our results demonstrated that STAT3 signaling pathway was involved in pancreatic cancer cell invasion and EMT, and that EMT induced by IL-6 was associated with the activation of STAT3 signaling pathway. Inhibition of STAT3 signaling pathway by silencing of the STAT3 gene with RNAi blocked STAT3 signaling pathway activation and suppressed EMT in pancreatic cancer cells. Collectively, the STAT3 signaling pathway plays an important role in the process of EMT of pancreatic cancer by regulating Snail gene expression. Better understanding of STAT3 signaling pathways in EMT may contribute to development of novel therapeutic strategies in invasion and metastasis of pancreatic cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21744993     DOI: 10.4149/neo_2011_05_396

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  31 in total

1.  Interleukin-6 promotes pancreatic cancer cell migration by rapidly activating the small GTPase CDC42.

Authors:  Gina L Razidlo; Kevin M Burton; Mark A McNiven
Journal:  J Biol Chem       Date:  2018-05-31       Impact factor: 5.157

Review 2.  Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application.

Authors:  V Taucher; H Mangge; J Haybaeck
Journal:  Cell Oncol (Dordr)       Date:  2016-04-08       Impact factor: 6.730

Review 3.  Crosstalk of Sp1 and Stat3 signaling in pancreatic cancer pathogenesis.

Authors:  Chen Huang; Keping Xie
Journal:  Cytokine Growth Factor Rev       Date:  2012-02-16       Impact factor: 7.638

4.  High level interleukin-6 in the medium of human pancreatic cancer cell culture suppresses production of neurotransmitters by PC12 cell line.

Authors:  Rong Li; Jian Hou; Qing Xu; Qing-Jun Liu; Yi-Jun Shen; Gary Rodin; Madeline Li
Journal:  Metab Brain Dis       Date:  2011-11-23       Impact factor: 3.584

Review 5.  Vascular mimicry: Triggers, molecular interactions and in vivo models.

Authors:  Stephen L Wechman; Luni Emdad; Devanand Sarkar; Swadesh K Das; Paul B Fisher
Journal:  Adv Cancer Res       Date:  2020-07-16       Impact factor: 6.242

6.  STAT3 integrates cooperative Ras and TGF-β signals that induce Snail expression.

Authors:  M Saitoh; K Endo; S Furuya; M Minami; A Fukasawa; T Imamura; K Miyazawa
Journal:  Oncogene       Date:  2015-05-11       Impact factor: 9.867

Review 7.  The wound healing, chronic fibrosis, and cancer progression triad.

Authors:  Brad Rybinski; Janusz Franco-Barraza; Edna Cukierman
Journal:  Physiol Genomics       Date:  2014-02-11       Impact factor: 3.107

8.  PIAS1 inhibited the metastasis of gastric cancer cell by epithelial-mesenchymal transition regulation within the inflammatory microenvironment.

Authors:  Xiaoyu Wang; Libing Wang; Yan Xu; Guohua Zhang; Yunlin Wu; Ping Chen
Journal:  Oncol Lett       Date:  2018-01-16       Impact factor: 2.967

9.  miR-519 inhibits epithelial-mesenchymal transition and biologic behavior of gastric cancer cells by down-regulating FOXQ1.

Authors:  Jiapeng Xu; Qing You; Ziran Wei; Hongbing Fu; Yu Zhang; Zunqi Hu; Qingping Cai
Journal:  Int J Clin Exp Pathol       Date:  2020-03-01

10.  Activated macrophages down-regulate expression of E-cadherin in hepatocellular carcinoma cells via NF-κB/Slug pathway.

Authors:  Xianteng Wang; Hao Wang; Guosheng Li; Yonghong Song; Shurong Wang; Faliang Zhu; Chun Guo; Lining Zhang; Yongyu Shi
Journal:  Tumour Biol       Date:  2014-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.